表紙
市場調査レポート

Cadila Pharmaceuticals Ltd.の製品パイプライン分析

Cadila Pharmaceuticals Ltd. - Product Pipeline Review - 2014

発行 Global Markets Direct 商品コード 192513
出版日 ページ情報 英文 28 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
Cadila Pharmaceuticals Ltd.の製品パイプライン分析 Cadila Pharmaceuticals Ltd. - Product Pipeline Review - 2014
出版日: 2014年05月30日 ページ情報: 英文 28 Pages
概要

ジェネリック医薬品企業であるCadila Pharmaceuticals Ltd.では、ヒト用および動物用の医薬品、バイオ製品、診断キット、医薬品原薬(API)および植物組織培養製品を提供しています。同社の製品は、鎮痛剤、造血剤、抗感染症、心血管系、眼科、消化器系、呼吸器系、抗糖尿病、抗生物質、免疫系など、様々なアプリケーションで見受けられます。

当レポートでは、Cadila Pharmaceuticals Ltd.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Cadila Pharmaceuticals Ltd.の基本情報

Cadila Pharmaceuticals Ltd.の概要

  • 主要情報
  • 企業情報

Cadila Pharmaceuticals Ltd.:R&Dの概要

  • 主な治療範囲

Cadila Pharmaceuticals Ltd.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • パートナー製品
    • パートナー製品/併用療法モダリティ

Cadila Pharmaceuticals Ltd.:パイプライン製品の概況

  • 最終段階にあるパイプライン製品
    • 第III相にある製品/併用療法モダリティ
  • 治験段階にあるパイプライン製品
    • 第II相にある製品/併用療法モダリティ
    • 第I相にある製品/併用療法モダリティ

Cadila Pharmaceuticals Ltd.:薬剤プロファイル

  • Centatin
  • CADI-05
  • 麻疹生ワクチン
  • 麻疹および風疹ワクチン

Cadila Pharmaceuticals Ltd.:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Cadila Pharmaceuticals Ltd.:最近のパイプライン動向

Cadila Pharmaceuticals Ltd.:休止中のプロジェクト

Cadila Pharmaceuticals Ltd.:本社と子会社の所在地

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC04888CDB

Global Markets Direct's, 'Cadila Pharmaceuticals Ltd. - Product Pipeline Review - 2014', provides an overview of the Cadila Pharmaceuticals Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Cadila Pharmaceuticals Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Cadila Pharmaceuticals Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Cadila Pharmaceuticals Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Cadila Pharmaceuticals Ltd.'s pipeline products

Reasons to buy

  • Evaluate Cadila Pharmaceuticals Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Cadila Pharmaceuticals Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Cadila Pharmaceuticals Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Cadila Pharmaceuticals Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Cadila Pharmaceuticals Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Cadila Pharmaceuticals Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Cadila Pharmaceuticals Ltd. Snapshot
    • Cadila Pharmaceuticals Ltd. Overview
    • Key Information
    • Key Facts
  • Cadila Pharmaceuticals Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Cadila Pharmaceuticals Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
    • Cadila Pharmaceuticals Ltd. - Pipeline Products Glance
      • Cadila Pharmaceuticals Ltd. - Late Stage Pipeline Products
        • Phase III Products/Combination Treatment Modalities
      • Cadila Pharmaceuticals Ltd. - Clinical Stage Pipeline Products
        • Phase II Products/Combination Treatment Modalities
        • Phase I Products/Combination Treatment Modalities
    • Cadila Pharmaceuticals Ltd. - Drug Profiles
      • Centatin
        • Product Description
        • Mechanism of Action
        • R&D Progress
      • CADI-05
        • Product Description
        • Mechanism of Action
        • R&D Progress
      • Live Measles Vaccine
        • Product Description
        • Mechanism of Action
        • R&D Progress
      • Measles and Rubella Vaccine
        • Product Description
        • Mechanism of Action
        • R&D Progress
    • Cadila Pharmaceuticals Ltd. - Pipeline Analysis
      • Cadila Pharmaceuticals Ltd. - Pipeline Products by Target
      • Cadila Pharmaceuticals Ltd. - Pipeline Products by Route of Administration
      • Cadila Pharmaceuticals Ltd. - Pipeline Products by Molecule Type
      • Cadila Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action
    • Cadila Pharmaceuticals Ltd. - Recent Pipeline Updates
    • Cadila Pharmaceuticals Ltd. - Dormant Projects
    • Cadila Pharmaceuticals Ltd. - Locations And Subsidiaries
      • Head Office
      • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Cadila Pharmaceuticals Ltd., Key Information
  • Cadila Pharmaceuticals Ltd., Key Facts
  • Cadila Pharmaceuticals Ltd. - Pipeline by Indication, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Stage of Development, 2014
  • Cadila Pharmaceuticals Ltd. - Monotherapy Products in Pipeline, 2014
  • Cadila Pharmaceuticals Ltd. - Partnered Products in Pipeline, 2014
  • Cadila Pharmaceuticals Ltd. - Partnered Products/ Combination Treatment Modalities, 2014
  • Cadila Pharmaceuticals Ltd. - Phase III, 2014
  • Cadila Pharmaceuticals Ltd. - Phase II, 2014
  • Cadila Pharmaceuticals Ltd. - Phase I, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Target, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Route of Administration, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Molecule Type, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action, 2014
  • Cadila Pharmaceuticals Ltd. - Recent Pipeline Updates, 2014
  • Cadila Pharmaceuticals Ltd. - Dormant Developmental Projects,2014
  • Cadila Pharmaceuticals Ltd., Other Locations

List of Figures

  • Cadila Pharmaceuticals Ltd. - Pipeline by Top 10 Indication, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Stage of Development, 2014
  • Cadila Pharmaceuticals Ltd. - Monotherapy Products in Pipeline, 2014
  • Cadila Pharmaceuticals Ltd. - Partnered Products in Pipeline, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Top 10 Target, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Top 10 Route of Administration, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Top 10 Molecule Type, 2014
Back to Top